Literature DB >> 20554741

PET/CT enterography in Crohn disease: correlation of disease activity on CT enterography with 18F-FDG uptake.

David Groshar1, Hanna Bernstine, Dorit Stern, Jacob Sosna, Merab Eligalashvili, Evren G Gurbuz, Yaron Niv, Gerald Fraser.   

Abstract

UNLABELLED: We combined (18)F-FDG PET and CT enterography in a single examination and compared the level of (18)F-FDG uptake measured by maximal standardized uptake value (SUVmax) with the CT enterography patterns of disease activity found in patients with Crohn disease (CD).
METHODS: Twenty-eight patients (mean age, 37.5 y; 11 male and 17 female) suspected of having active CD underwent PET/CT enterography. Abnormal bowel segments recognized on CT enterography were graded qualitatively for the presence of perienteric fat infiltration, the comb sign, and intramural attenuation and by quantitative measurements of mural enhancement (Hounsfield units) and thickness (mm). Also, for each patient, normal segments of the ileum and colon were noted, and CT enterography measurements of thickness and enhancement were obtained. For segments detected on CT enterography, a volume of interest was placed on the fused (18)F-FDG PET scan, and the SUVmax was obtained.
RESULTS: Of the 28 patients with suspected active CD, 22 had 85 abnormal segments and 6 had no abnormal segments. SUVmax was significantly higher in the abnormal segments than in the normal segments (5.0 +/- 2.5 [95% confidence interval, 4.5-5.5] and 2.1 +/- 0.69 [95% confidence interval, 1.9-2.2], respectively; P < 0.0001). A good correlation was found between SUVmax with CT enterography measurements of mural thickness and enhancement (P < 0.00001). There was a significant difference in SUVmax between the 3 levels of disease activity found by intramural attenuation, perienteric fat infiltration, and the comb sign on CT enterography. SUVmax was significantly higher when there were intense CT enterography findings of active disease (P < 0.001).
CONCLUSION: SUVmax assessment may allow an objective, reliable indication of the grade and severity of inflammation activity in abnormal segments of the bowel detected by CT enterography.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554741     DOI: 10.2967/jnumed.109.073130

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

1.  PET/CT in the diagnosis of inflammatory bowel disease in pediatric patients: a review.

Authors:  Mikkel Malham; Søren Hess; Rasmus G Nielsen; Steffen Husby; Poul Flemming Høilund-Carlsen
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-04-25

2.  FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity.

Authors:  Babak Saboury; Ali Salavati; Alex Brothers; Sandip Basu; Thomas C Kwee; Marnix G E H Lam; Roland Hustinx; Edouard Louis; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-20       Impact factor: 9.236

Review 3.  PET-CT in children: where is it appropriate?

Authors:  Sue C Kaste
Journal:  Pediatr Radiol       Date:  2011-08-17

4.  Small bowel imaging of inflammatory bowel disease.

Authors:  Emanuele Casciani; Chiara De Vincentiis; Gianfranco Gualdi
Journal:  World J Radiol       Date:  2015-08-28

Review 5.  Imaging of the small bowel: Crohn's disease in paediatric patients.

Authors:  Emanuele Casciani; Chiara De Vincentiis; Elisabetta Polettini; Gabriele Masselli; Giovanni Di Nardo; Fortunata Civitelli; Salvatore Cucchiara; Gian Franco Gualdi
Journal:  World J Radiol       Date:  2014-06-28

Review 6.  Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers.

Authors:  Vetri Sudar Jayaprakasam; Viktoriya Paroder; Heiko Schöder
Journal:  Semin Nucl Med       Date:  2021-05-06       Impact factor: 4.802

7.  Carcinoma of unknown primary of neuroendocrine origin: Accurate detection of primary with (68)Ga-labelled [1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid]-1-NaI3-Octreotide positron emission tomography/computed tomography enterography.

Authors:  Tarun Kumar Jain; Sellam Karunanithi; Varun Singh Dhull; Shambo Guha Roy; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2014-04

8.  Diagnosis of Men-I Syndrome on (68)Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With (177)Lu-DOTATATE.

Authors:  Santosh Kumar Gupta; Suhas Singla; Nishikant A Damle; Krishankant Agarwal; Chandersekhar Bal
Journal:  Int J Endocrinol Metab       Date:  2012-09-30

9.  Radionuclide small intestine imaging.

Authors:  Jiri Dolezal; Marcela Kopacova
Journal:  Gastroenterol Res Pract       Date:  2013-05-30       Impact factor: 2.260

Review 10.  The Role of MR Enterography in Assessing Crohn's Disease Activity and Treatment Response.

Authors:  Matthew P Moy; Jenny Sauk; Michael S Gee
Journal:  Gastroenterol Res Pract       Date:  2015-12-27       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.